Program I status unquestionably increases the volume of complexity for virtually any exploration review. One example is, all researchers—regardless of whether preclinical or medical—need to attain Agenda I analysis registrations. 21 CFR part 1301.18. By contrast, researchers who have DEA Practitioner registrations in Schedules II–V (which mos